Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB26FM8EQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,849
Award facts
- Contract value 100% obligated
- $6,848.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,848.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The product will be delivered to Park Ridge, Illinois and supports the Department of Defense's pharmaceutical supply requirements.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The PPV-G GEN V contract, valued at $499.9 million with a ceiling through December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of branded and generic prescription drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally. The contractor's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FM8EQ?
SPE2DB26FM8EQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FM8EQ worth?
The government has obligated $6,849 on SPE2DB26FM8EQ.
Is contract SPE2DB26FM8EQ an order under another contract?
Yes. SPE2DB26FM8EQ is a delivery order under SPE2DB22D9151, an indefinite delivery contract.
Was contract SPE2DB26FM8EQ competed?
The extent of competition for SPE2DB26FM8EQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award